Humana (HUM)
(Delayed Data from NYSE)
$247.26 USD
-2.61 (-1.04%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $247.14 -0.12 (-0.05%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth A Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Humana Inc. has a PEG ratio of 1.41 compared to the Medical - HMOs industry's PEG ratio of 1.11.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
HUM 247.26 -2.61(-1.04%)
Will HUM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for HUM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HUM
Why Humana (HUM) is a Top Momentum Stock for the Long-Term
HUM Misses Q2 Earnings on Higher Benefit Costs, Ups '25 EPS View
HUM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's What Key Metrics Tell Us About Humana (HUM) Q2 Earnings
CVS Health Care Delivery: Will the Growth Momentum Last in Q2?
Humana (HUM) Q2 Earnings Lag Estimates
Other News for HUM
Barclays Raises Price Target for Humana (HUM) to $275 | HUM Stock News
Humana (HUM) Target Price Lowered by Morgan Stanley | HUM Stock News
Humana (HUM) Expands Cancer Screening Accessibility with New Partnership
Humana (HUM) Target Price Reduced by Piper Sandler
Exact Sciences expands colorectal cancer screening partnership with Humana